Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Dis Colon Rectum. 2021 May;64(5):555–562. doi: 10.1097/DCR.0000000000001872

TABLE 3.

Univariable analysis of factors potentially associated with disease-specific survival in patients who received immunotherapy (n = 29)

Variable (n) Median survival
(mo.)
5-year survival
(%)
p
Age
 ≤60 y (16) 54.8 42 0.52
 >60 y (13) NR 55
Sex
 Female (13) 37.5 37.5 0.94
 Male (16) 88.5 51
Presentation
 Anemia (14) 54.8 41 0.45
 Mass (11) 88.5 57
 Pain (1) NR NR
 Colonoscopy (3) 18.9 NR
Site or origin
 Anorectal (15) 88.5 70 0.42
 Perianal (7) 54.8 NR
 Rectum (7) 30.6 43
Ballantyne stage
 I (18) 88.5 52 0.58
 II (11) NR 51
Type of Surgery
 APR (8) 27.6 19 0.19
 LE (21) 88.5 65
Margins
 R0 (15) 37.5 48 0.49
 R1/2 (13) NR 58
LVI
 Yes (11) 23.4 50 0.17
 No (7) NR 71
PNI 0.16
 Yes (3) NR 33
 No (9) 30.6 77
Depth
 ≥10 mm (13) NR 55 0.58
 <10 mm (12) 54.8 20
Systemic chemotherapy
 Yes (13) 30.6 39 0.43
 No (16) 88.5 61
Locoregional radiation
 Yes (8) 88.5 52 0.96
 No (21) NR 52

NR, not reached; APR, abdominoperineal resection; LE, local excision; LVI, lymphovascular invasion; PNI, perineural invasion.